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clear and becomes crucial during the first 2 months of life, 
even when excluding etiological factors. Nevertheless, age 
cannot be considered the only parameter of the decision-
making process, especially in these very young patients. 
Probably, the definition of ‘unsuccessful ETV’ should be re-
evaluated in light of decreased risk of shunt malfunction ob-
served after a failed ETV. 
 
Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Endoscopic third ventriculostomy (ETV) is a well-es-
tablished procedure for the treatment of obstructive hy-
drocephalus although outcome is reported to be worse in 
small children and especially in infants. Conflicting re-
ports on which patients are most likely to benefit from the 
procedure are animating the neurosurgical literature. 
The debate mainly focuses on the influence of age  [1–6] , 
etiology  [7–15] , or both  [16–20] , and on the success rates 
of ETV.
 Publications in favor of an influence of age on ETV 
success highlight the highest failure rates in children be-
low a defined age cutoff ranging from 6 months to 2 years; 
however, the worst outcome and controversies concern 
the population of premature newborns and infants less 
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 Abstract 
 Background: The failure rate following endoscopic third 
ventriculostomy (ETV) in infants younger than 2 years of age 
has been reported to be higher compared with that of older 
children, and it is unclear whether ETV might be superior to 
shunt placement in this age group.  Methods: Between 2003 
and 2009, 23 patients younger than 6 months and without a 
previous history of shunting underwent ETV in our institu-
tion. A review of the literature was performed on the basis of 
publications presenting detailed data on age and etiology in 
every single patient.  Results: In our own patients, total suc-
cess rate was 39.1%. In the successful cases, median age was 
140 days, whereas in the unsuccessful cases it was 47 days. 
The difference between the two groups was statistically sig-
nificant (p = 0.01). The median ages of both successful and 
unsuccessful groups corresponded to data gained from an 
analysis of the literature (p = 0.04). At a median follow-up of 
47 months, 2 out of 14 patients shunted after a failed ETV 
were revised for ventriculoperitoneal shunt malfunction. 
 Conclusion: The impact of age on ETV failure in infants is 
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than 6 months of age with several studies showing suc-
cess rate of ETV ranging from 0 to 67%  [2, 10, 12, 15, 18, 
21–26] .
 We retrospectively analyzed the data of 23 infants 
younger than 6 months with obstructive hydrocephalus 
admitted to our Pediatric Neurosurgical Unit in Bron 
(Lyon) who underwent ETV, as a first choice of treatment, 
with the intent to assess its effectiveness and discuss the 
reasons of its failure. We also performed a review of the 
literature looking for a possible dependence of ETV fail-
ure on age or etiology of hydrocephalus.
 Material and Methods 
 Between January 2003 and September 2009, 183 pediatric 
ETVs (population younger than 18 years) were performed, includ-
ing 23 infants less than 6 months of age with diagnosed obstruc-
tive hydrocephalus and without a previous history of shunting. In 
the 23 patients considered in our study, age ranged from 1 to 170 
days with a median age of 70 days, and male:female ratio was
11: 12. Diagnosis of hydrocephalus was made on the basis of clin-
ical manifestation and on the basis of magnetic resonance imag-
ing (MRI) in the majority of cases or indirectly inferred from tri-
ventricular dilatation in CT scan or ultrasound examination.
Idiopathic aqueductal stenosis (IAS) was the etiology of hydro-
cephalus in 10 infants. The other etiologies were posthemorrhag-
ic hydrocephalus (PHH) in 4 patients, posterior fossa cysts in
3 pa tients, Dandy-Walker malformation in 2 patients, Chiari I 
malformation in 1 patient, quadrigeminal cyst in 1 patient, hydro-
cephalus associated with occipital encephalocele in 1 patient and 
triventricular hydrocephalus in 1 patient with achondroplasia. 
No children had a shunt device before ETV. Patients with Dandy-
Walker malformation and the patient with quadrigeminal cyst 
also underwent endoscopic cystocisternostomy during the same 
surgery. The patient with occipital encephalocele developed hy-
drocephalus 4 months after the excision of the encephalocele sac 
with repair of the defect had been conducted. A summary of pa-
tient characteristics and outcome is listed in  table 1 .
 ETV procedures were performed with a rigid endoscope 
(Hopkins 30°, Karl Storz, Tuttlingen, Germany) at the lateral edge 
of the open anterior fontanel or a right frontal burr hole placed 
slightly anterior to the coronal suture and medial to the midpupil-
lary line. The same procedure was followed in all cases: the third 
ventricular floor was fenestrated between the mamillary bodies 
Table 1.  Summary of patient characteristics and outcomes
Patient/sex Age
days
Diagnosis Preoperative signs/
symptoms
Procedure Re-ETV Complications Outcome1 Follow-up
months
VPS revisions
n
1 AA/F 142 IAS tense AF and IHC ETV – – VPS (8) 49 –
2 BK/F 55 PFC vomiting and setting-
sun sign
ETV – – VPS (20) 12 –
3 BM/F 139 IAS tense AF and IHC ETV after 26 days – VPS (40) 64 –
4 BA/M 65 DWM tense AF and IHC ETV + ECC – – VPS (42) 19 –
5 BL/F 1 PHH antenatal diagnosis ETV – – VPS (13) 84 1 (after 17 months) 
6 CT/F 36 DWM tense AF, IHC and
drowsiness
ETV + ECC – – VPS (22) 19 –
7 CJ/M 83 AH antenatal diagnosis ETV – – VPS (29) 67 –
8 DJ/F 6 IAS antenatal diagnosis ETV – – VPS (132) 45 –
9 DA/F 31 PHH antenatal diagnosis ETV – – VPS (11) 75 2 (after 11 and 41 
months)
10 DS/M 150 OEH setting-sun sign ETV – – shunt-free 6 –
11 FA/M 170 CM tense AF and IHC ETV – – shunt-free 81 –
12 FF/F 18 QC antenatal diagnosis ETV + ECC – seizures VPS (105) 6 –
13 FA/F 15 IAS antenatal diagnosis ETV – – shunt-free 50 –
14 FC/F 169 IAS tense AF and IHC ETV – – shunt-free 58 –
15 GM/M 140 IAS tense AF and IHC ETV – – shunt-free 49 –
16 KT/M 95 PFC IHC ETV – – shunt-free 73 –
17 LE/M 157 IAS tense AF and IHC ETV – – shunt-free 72 –
18 MS/M 80 PHH tense AF and IHC ETV – – VPS (66) 84 –
19 MG/M 39 IAS IHC ETV – – VPS (15) 12 –
20 ML/F 138 IAS IHC and large head ETV – – shunt-free 84 –
21 RL/M 34 PHH antenatal diagnosis ETV – – VPS (14) 84 –
22 SD/F 70 PFC tense AF, IHC,
vomiting
ETV – – VPS (7) 26 –
23 WL/M 45 IAS IHC ETV – forniceal injury shunt-free 15 –
1  The interval between ETV and shunt insertion is given in parentheses (days).
PFC = Posterior fossa cyst; DWM = Dandy-Walker malformation; OEH = occipital encephalocele-associated hydrocephalus; CM = Chiari I malfor-
mation; QC = quadrigeminal cyst; AF = anterior fontanel; IHC = increased head circumference; ECC =  endoscopic cystocisternostomy.
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and the infundibular recess by applying brief pulses of bipolar 
coagulation on the surface followed by blunt penetration through 
the floor; a Fogarty microballoon catheter was used to dilate the 
opening. The endoscope was passed through the opening in the 
floor and, when necessary, additional intracisternal blunt dissec-
tion was performed until the direct visualization of the structures 
of the interpeduncular and prepontine cistern was obtained. 
Sparse ventricular bleeding was easily controlled by gentle irriga-
tion with normal saline solution at body temperature. No patient 
in this series had substantial intraventricular hemorrhage during 
surgery requiring extraventricular drainage postoperatively.
 Complications of the endoscopic procedure included early 
postoperative seizures in 1 patient and an intraoperative forniceal 
injury in another patient. No postoperative infection, hemor-
rhage or cerebrospinal fluid (CSF) leak was observed in this series 
of patients.
 During the follow-up period, all children underwent postop-
erative clinical evaluation and neurodiagnostic imaging (MRI or 
CT scan). Ventriculoperitoneal shunt (VPS) was recommended 
for infants who did not experience improvement in clinical signs 
of hydrocephalus or who relapsed. In children who improved af-
ter ETV, MRI was done at 3 months or later; serial clinical evalu-
ations were performed at 2 and 6 months and then yearly. ETV 
was judged to be successful when shunting could be avoided.
 Statistical Analysis 
 Statistical analysis was performed on Graph Pad Prism 4.0 us-
ing the Mann-Whitney U nonparametric test to analyze the dif-
ferences between groups. Values of p  ! 0.05 were considered sta-
tistically significant.
 Results 
 Overall, at a median follow-up period of 50 months 
(range 6–84) ETV was successful in 9 of the 23 patients 
(39.1%). In infants with a successful ETV the median fol-
low-up period was 58 months (range 6–84). In the re-
maining 14 patients (60.9%) with unsuccessful ETV, VPS 
was performed. The interval between ETV and shunt in-
sertion ranged from 7 to 132 days with an average of 37.4 
days. In 1 patient, repeat ETV was performed 26 days af-
ter the first ETV; however, he ended up in ventriculoperi-
toneal shunt insertion because of recurrence of clinical 
and radiological signs of hydrocephalus 2 weeks later.
In the 9 successful cases, etiology was IAS in 6 patients, 
Chiari I malformation in 1 patient, posterior fossa cyst in 
1 patient and occipital encephalocele in 1 patient; the me-
dian age of this group was 140 days and the mean age 119 
days (range 15–170). In the ETV failure group the median 
age was 47 days and the mean age 57 days (range 1–142). 
The differences between the two groups were statistically 
significant (p = 0.01) and the age distribution showed a 
strong tendency for failure to occur more frequently in 
the first 2 months of life. When analyzing infants only 
with IAS (only 10 patients), similar distributions, but not 
significant (p = 0.47), were found ( fig. 1 ).
 In patients younger than 2 months (n = 10), success 
rate was 20% while in patients from 2 to 6 months of age 
(n = 13), success rate was 53.8%. The highest success rate 
was obtained in the primary aqueductal stenosis group 
with a successful ETV in 6 out of 10 patients. In infants 
with IAS younger than 2 months (n = 4) the success rate 
was 50%, whereas in patients from 2 to 6 months (n = 6) 
it was 66.6%. In patients with etiology other than IAS
(n = 13) success rate of ETV was 23% and all successful 
procedures were performed in infants older than 2 
months of age.
 At a median follow-up of 47 months, 2 out of 14 infants 
(14.2%) shunted after a failed ETV have been surgically 
revised for VPS malfunction. Both were 1 month old and 
underwent ETV for PHH. The first had one episode
of VPS malfunction after 17 months from the implant, 
whereas the other had two episodes after 11 and 41 
months, respectively.
 Analysis of Literature Data 
 Careful analysis of the literature, looking for a possible 
dependency of ETV failure on age or etiology of hydro-
cephalus, was performed on the basis of publications pre-
senting sufficiently detailed data of every single patient 
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 Fig. 1. Bar graph showing age distribution 
in both outcome groups (our own series). 
 a For all patients.  b For patients with IAS. 
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(e.g. in the form of tables presenting raw data) to allow an 
exact analysis of both patient age and etiology of the hy-
drocephalus. Only infants younger than 6 months of age, 
who underwent ETV as a first choice of treatment and 
with follow-up times of at least 6 months, if not shunted, 
were included in the meta-analysis.
 The publications selected for meta-analysis  [2, 4, 21, 
22, 24, 27–30] give detailed data on ETV outcome in 53 
infants (median age 86 days).
 Overall, ETV was successful in 21 patients (39.6%) and 
eventually failed in 32 patients. In infants with a success-
ful ETV median age was 120 days and mean age 107 days 
(range 0–183), whereas in nonsuccessful cases median 
age was 60 days and mean age 78 days (range 8–188). The 
differences were statistically significant (p = 0.04). In pa-
tients younger than 2 months of age (n = 22), success rate 
was 22.7% while in patients from 2 to 6 months of age
(n = 31), success rate was 51.6%.
 In the IAS group (n = 20), ETV was successful in 50% 
of cases. Median and mean ages were 135 and 112 days, 
respectively, in successful cases and 33 and 40 days in un-
successful cases. The differences were statistically signif-
icant (p = 0.03) with a success rate in infants less and 
older than 2 months of age of 25 and 87.5%, respectively 
( fig. 2 ). The success rate of ETV in patients with etiology 
other than IAS (n = 33) was 33%.
 Discussion 
 The analysis of the literature, confirming our data, 
shows that overall success rate of ETV, as a first choice of 
treatment, for children younger than 6 months is about 
40%. This finding is also supported by the recent publica-
tion by Kulkarni et al.  [3] that assessed ETV outcome in 
a large cohort of children (618 patients younger than 19 
years) collected from a collaborative international net-
work and developed a simplified scoring system to pre-
dict a successful ETV. This is one of the largest sample 
sizes currently in the literature validated with a rigorous 
statistical technique. In their study, age was the strongest 
predictor of success with infants, especially those young-
er than 6 months (99 patients), having the lowest predict-
ed ETV success (44.4%) with progressively higher success 
seen as a child ages; the effect of etiology and presence of 
a previous CSF shunt appeared to be significant but much 
less in magnitude than age.
 Warf et al.  [31] reported an impressive single-center 
prospective series of children treated with ETV; the suc-
cess rate of the procedure in infants younger than 6 
months was 34%. However, two remarkable peculiarities 
of this study must be pointed out: the dominant etiologies 
of postinfectious and myelomeningocele-associated hy-
drocephalus and the unilateral/bilateral choroid plexus 
cauterization performed during the endoscopic proce-
dure.
 The finding of a probability of ETV success gradually 
increasing over time during the first year of life is con-
firmed also by a retrospective German multicenter study 
 [32] and by the large series reported from Jones et al.  [33] .
 When we analyzed the age distribution of ETV out-
come in our population study and in the analysis of the 
literature, we found a tendency for failures to occur more 
frequently in the first 2 months. The existence of a cutoff 
age for the success rate of ETV during the first 6 months 
was reported by other studies  [22, 25, 34] , also in the se-
ries of Ogiwara et al.  [26] only based on infants younger 
than 6 months.
 We are convinced that something happens over the 
course of time that changes the pathophysiology of CSF 
flow and increases the success rate of ETV over time. An-
other factor influencing the lower reported success rate 
in younger infants is, probably, the definition of ‘unsuc-
cessful ETV’. Considering a longer time of adaptation, in 
comparison with adults, as the reason of persistence of 
higher ICP despite a good stoma  [35] , we think that some 
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in both outcome groups (data from the lit-
erature).  a For all patients.  b For patients 
with IAS. 
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patients (even in our group) are evaluated as unsuccessful 
and shunted too early.
 Regarding the etiology of hydrocephalus, our study, 
supported by the analysis of the literature, confirms the 
highest previously reported ETV success rate worldwide 
in infants with triventricular hydrocephalus caused by 
isolated primary aqueductal stenosis and a very low suc-
cess rate in patients with PHH.
 Patients with PHH, in our series, were all younger 
than 3 months of age and ETV eventually failed in all 
cases. The median interval between ETV and shunt in-
sertion was 13.5 days. Our failure in PHH is in line with 
many reports in the literature and reflects our inability, 
to date, to determine the contribution of hyporesorption 
in patients with PHH or postinfectious hydrocephalus.
 In case of PHH, a promising approach is to determine 
the proportion of hyporesorption by examining the 
transforming growth factor- ! 1 level in CSF, as recently 
reported by Lipina et al.  [36] . In our opinion, their study 
opens up a new scenario for decision making in PHH and 
goes in the right direction: improving patient selection by 
use of biological markers waiting for a progress in imag-
ing tools. Nevertheless, to date, taking an accurate medi-
cal history from the parents (any suggestion of postnatal 
or prenatal bleeding, fetal infection or postnatal menin-
gitis must not be overlooked) remains the first step to-
wards identifying possible risk factors for an underlying 
problem associated with, or leading to, impaired absorp-
tion of CSF  [37] .
 An interesting finding in our series is that patients 
shunted after a failed ETV showed a decreased risk of 
shunt malfunction compared with our own previous ex-
perience and with the known risk of shunt malfunction 
in shunted hydrocephalic patients reported in the litera-
ture  [38, 39] .
 We revised only 2 patients out of 14 (14.2%) during a 
median follow-up time of 47 months. This phenomenon, 
that a failed ETV may have some advantages over time in 
terms of lower revision rate, was also observed by Beem 
and Grotenhuis  [40] .
 Shim et al.  [41]  compared the outcome of 31 infants 
treated with implantation of VPS and ETV and of 45 in-
fants treated only with VPS. They found a higher success 
rate in the VPS plus ETV group (success was defined as 
no need for any subsequent surgical procedure of CSF 
diversion) with remarkable results in PHH and postmen-
ingitic hydrocephalus. They did not try to provide evi-
dence for the continuing patency of any of the ETVs or 
VPSs and suggested that the functioning procedure in 
the VPS plus ETV group could replace the malfunction-
ing one  [41] . We do not speculate about this phenomenon 
but we think that it deserves further investigation.
 Despite the increasing popularity of ETV, there is no 
consensus on which is the treatment of choice for infan-
tile hydrocephalus. Controversy continues over which 
are appropriate candidates for the endoscopic procedure 
essentially because of our incomplete understanding of 
hydrocephalus and, above all, of the embryogenesis and 
the morphological/functional development of CSF dy-
namics. Despite a variety of classification systems for hy-
drocephalus have been suggested  [17, 42–47] , the conven-
tional ‘bulk flow’ model  [48] – even if it fails to explain 
other forms of hydrocephalus than that caused by ob-
struction of the intraventricular CSF pathways or ven-
tricular outflow – remains the most attractive for neuro-
surgeons probably because, beyond the descriptive and 
simplified aspect of hydrocephalus, it implies alternatives 
of treatments.
 However, in the last years, the concept of communi-
cating versus obstructive hydrocephalus has been chal-
lenged; it was suggested that variable sites for obstruction 
to flow may be important for treatment, and that there 
could be a number of parallel flow routes that are geneti-
cally determined and age-dependent  [49, 50] .
 The hydrodynamic hypothesis suggested by Greitz et 
al.  [51] and Greitz [52]  considers, in addition to a pure 
bulk flow problem, the dynamic pulsatile nature of the 
CSF movement in concert with the venous and arterial 
pulsatility and the pulsatile movement of the brain itself. 
The hydrodynamic viewpoint could explain how, apart 
from the intraventricular interruption of CSF bulk flow, 
an obstruction of the intraventricular and extraventricu-
lar CSF spaces changes local and global compliance and 
in consequence, pulsatility patterns, which leads to a hy-
drocephalic condition  [51, 52] . Future therapy of pediat-
ric hydrocephalus could be improved when more detailed 
knowledge of the CSF flow routes and cerebral hydrody-
namics is forthcoming.
 Conclusion 
 Based on our data, on the review of the literature and 
above-mentioned citations we can doubtless affirm that 
the pathophysiology of hydrocephalus remains the very 
Achilles’ heel of any treatment paradigms of infantile hy-
drocephalus.
 The major limit of all case series in the literature, even 
in our study, is the unavoidable subjectivity in defining 
etiology – secondary versus primary aqueductal steno-
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sis – and ‘unsuccessful ETV’ which follows the decision 
to shunt, which is, sometimes, too hasty considering the 
longer time of adaptation in infants. At the current state 
of knowledge, looking forward to the results of the ongo-
ing International Infant Hydrocephalus Study trial, the 
endeavor to improve success rate by selection of patients 
should not be exaggerated because the risk is to exclude 
some patients who might benefit from the procedure. In 
infants with etiology other than primary aqueductal ste-
nosis we probably have to reevaluate the definition of ‘un-
success’, considering also the finding that patients shunt-
ed after a failed ETV could present a decreased risk of 
shunt malfunction.
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